OP
AGN

Omni Partners’s Allergan plc AGN Stock Holding History

Omni Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-821,476
Closed -$145M – 82
2020
Q1 		$145M Sell
821,476
-308,484
-27% -$58.1M 12.81% 1
2019
Q4 		$216M Buy
1,129,960
+8,494
+0.8% +$1.53M 5.79% 3
2019
Q3 		$189M Buy
1,121,466
+905,466
+419% +$148M 13.69% 2
2019
Q2 		$36.2M Buy
+216,000
New +$29.9M 1.91% 14
2017
Q1 		– Sell
-20,000
Closed -$4.2M – 22
2016
Q4 		$4.2M Sell
20,000
-2,061
-9% -$427K 0.94% 18
2016
Q3 		$5.08M Buy
+22,061
New +$5.39M 1.48% 17
2016
Q2 		– Sell
-20,157
Closed -$5.4M – 24
2016
Q1 		$5.4M Buy
+20,157
New +$5.77M 2.53% 12

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Omni Partners's AGN Position: Q2 2020 in Review

Omni Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 821,476 shares — an estimated $145M sold.

Omni Partners first reported a position in AGN in Q1 2016 and held it in 7 quarters. The position peaked at $216M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Omni Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Omni Partners sold 821,476 Allergan plc shares in Q2 2020, an estimated $145M.
  • Omni Partners first reported a position in Allergan plc in Q1 2016 and held it in 7 quarters.
  • Omni Partners's Allergan plc position peaked at $216M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Omni Partners's 13F filing for Q2 2020, filed 14 Aug 2020.